Teri Schreiner

3.5k total citations
37 papers, 1.2k citations indexed

About

Teri Schreiner is a scholar working on Pathology and Forensic Medicine, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Teri Schreiner has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Teri Schreiner's work include Multiple Sclerosis Research Studies (14 papers), Viral Infections and Immunology Research (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Teri Schreiner is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Viral Infections and Immunology Research (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Teri Schreiner collaborates with scholars based in United States, Germany and Argentina. Teri Schreiner's co-authors include Kevin Messacar, John A. Maloney, Samuel R. Dominguez, Samuel R. Dominguez, W. Allan Nix, Kenneth L. Tyler, Mary P. Glodé, Michele Yang, Mark J. Abzug and Adam Wallace and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Teri Schreiner

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teri Schreiner United States 17 579 363 361 268 222 37 1.2k
Sylvia Frisancho‐Kiss United States 12 688 1.2× 127 0.3× 117 0.3× 47 0.2× 167 0.8× 12 1.5k
Anthony P. Fernandez United States 19 77 0.1× 198 0.5× 143 0.4× 75 0.3× 260 1.2× 90 1.1k
P. Disdier France 20 118 0.2× 146 0.4× 103 0.3× 149 0.6× 221 1.0× 149 1.5k
Sarah Hopkins United States 15 166 0.3× 97 0.3× 116 0.3× 105 0.4× 70 0.3× 43 824
Anna‐Maija Haapala Finland 21 49 0.1× 95 0.3× 114 0.3× 192 0.7× 334 1.5× 40 1.3k
Cendrine Chaffaut France 13 58 0.1× 93 0.3× 215 0.6× 194 0.7× 829 3.7× 30 1.3k
Susan Arbuckle Australia 23 68 0.1× 52 0.1× 124 0.3× 86 0.3× 365 1.6× 77 1.6k
Thijs Feuth Netherlands 19 111 0.2× 30 0.1× 130 0.4× 136 0.5× 197 0.9× 37 916
B.S. Singhal India 17 40 0.1× 265 0.7× 94 0.3× 199 0.7× 61 0.3× 30 657
Reuwen Achiron Israel 18 90 0.2× 95 0.3× 44 0.1× 45 0.2× 226 1.0× 42 1.1k

Countries citing papers authored by Teri Schreiner

Since Specialization
Citations

This map shows the geographic impact of Teri Schreiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teri Schreiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teri Schreiner more than expected).

Fields of papers citing papers by Teri Schreiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teri Schreiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teri Schreiner. The network helps show where Teri Schreiner may publish in the future.

Co-authorship network of co-authors of Teri Schreiner

This figure shows the co-authorship network connecting the top 25 collaborators of Teri Schreiner. A scholar is included among the top collaborators of Teri Schreiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teri Schreiner. Teri Schreiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mar, Soe, Massimiliano Valeriani, Barbara Steinborn, et al.. (2025). Ocrelizumab dose selection for treatment of pediatric relapsing–remitting multiple sclerosis: results of the OPERETTA I study. Journal of Neurology. 272(2). 137–137. 1 indexed citations
2.
Wolfe, Kelly R., et al.. (2024). Clinical utility of brief screening measures during neuropsychological consultation for pediatric onset multiple sclerosis. Journal of the International Neuropsychological Society. 30(10). 977–984. 1 indexed citations
3.
Pilloni, Giuseppina, T. Charles Casper, Soe Mar, et al.. (2024). Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational study. International Journal of Clinical and Health Psychology. 24(3). 100486–100486. 2 indexed citations
4.
Yeshokumar, Anusha K., et al.. (2022). Evaluation of multiple consensus criteria for autoimmune encephalitis and temporal analysis of symptoms in a pediatric encephalitis cohort. Frontiers in Neurology. 13. 952317–952317. 1 indexed citations
5.
Ghezzi, Angelo, Brenda Banwell, Amit Bar‐Or, et al.. (2020). Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Multiple Sclerosis Journal. 27(12). 1814–1822. 22 indexed citations
6.
Piquet, Amanda L., Judith E. A. Warner, Matthew Wicklund, et al.. (2019). Novel clinical features of glycine receptor antibody syndrome. Neurology Neuroimmunology & Neuroinflammation. 6(5). e592–e592. 41 indexed citations
7.
Messacar, Kevin, Emily Spence-Davizon, Christina Osborne, et al.. (2019). Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. The Lancet Infectious Diseases. 20(2). 230–239. 57 indexed citations
8.
Messacar, Kevin, Emily Spence-Davizon, Christina Osborne, et al.. (2019). Clinical Characteristics of Enterovirus A71 Neurologic Disease During an Outbreak in Children in Colorado, 2018. SSRN Electronic Journal. 1 indexed citations
9.
Brenton, J. Nicholas, et al.. (2017). Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis. Journal of Neurology. 265(2). 417–423. 10 indexed citations
10.
Messacar, Kevin, Michele Yang, John A. Maloney, et al.. (2017). Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology. 89(2). 129–137. 55 indexed citations
11.
Messacar, Kevin, Michele Yang, John A. Maloney, et al.. (2016). Neurologic Follow-Up of 12 Colorado Children with Acute Flaccid Myelitis at One Year (S10.004). Neurology. 86(16_supplement). 3 indexed citations
12.
Makhani, Naila & Teri Schreiner. (2016). Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study. Pediatric Neurology. 57. 101–104. 34 indexed citations
13.
14.
Olson, Daniel, Atle Møen, Emily Barr, et al.. (2015). An 8-Year-Old Boy With Ascending Paralysis. Journal of the Pediatric Infectious Diseases Society. 4(4). 385–388. 1 indexed citations
15.
Schreiner, Teri, et al.. (2014). Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells. Journal of Neuroimmunology. 270(1-2). 75–85. 17 indexed citations
16.
Maloney, John A., David M. Mirsky, Kevin Messacar, et al.. (2014). MRI Findings in Children with Acute Flaccid Paralysis and Cranial Nerve Dysfunction Occurring during the 2014 Enterovirus D68 Outbreak. American Journal of Neuroradiology. 36(2). 245–250. 126 indexed citations
17.
Miravalle, Augusto & Teri Schreiner. (2013). Neurologic complications of vaccinations. Handbook of clinical neurology. 121. 1549–1557. 7 indexed citations
18.
Parsons, Julie, Teri Schreiner, Donna Curtis, et al.. (2010). Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1). Archives of Neurology. 68(4). 455–455. 39 indexed citations
19.
Schreiner, Teri, et al.. (1997). Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra. Human Reproduction. 12(4). 703–705. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Frisancho‐Kiss Breakdown of academic impact, for papers by Anthony P. Fernandez Breakdown of academic impact, for papers by P. Disdier Breakdown of academic impact, for papers by Sarah Hopkins Breakdown of academic impact, for papers by Anna‐Maija Haapala Breakdown of academic impact, for papers by Cendrine Chaffaut Breakdown of academic impact, for papers by Susan Arbuckle Breakdown of academic impact, for papers by Thijs Feuth Breakdown of academic impact, for papers by B.S. Singhal Breakdown of academic impact, for papers by Reuwen Achiron
Rankless by CCL
2026